✦ LIBER ✦

S1131 Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn's Disease in the Care Trial

✍ Scribed by Edouard Louis; Robert Lofberg; Walter Reinisch; Martina Kron; Anne Camez; Anne Robinson; Paul F. Pollack

Book ID: 119430731
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 75 KB
Volume: 136
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(09)60880-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adalimumab produces clinical remission a

Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn's disease: Results from CARE

✍ Robert Löfberg; Edouard V. Louis; Walter Reinisch; Anne M. Robinson; Martina Kro 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB

Background: Data regarding the effectiveness of anti-tumor necrosis factor (TNF) agents for resolution of extraintestinal manifestations (EIMs) are scarce. The CARE study evaluated clinical effectiveness, EIM resolution, and safety of adalimumab in a large pan-European cohort of patients with modera

P118 - Adalimumab's effect on extraintes

P118 - Adalimumab's effect on extraintestinal manifestations of Crohn's disease: results of the CARE trial

✍ E. Louis; R. Lofberg; W. Reinisch; M. Kron; A. Camez; A. Robinson; P.F. Pollack 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 60 KB

S1167 Relationship Between Extraintestin

S1167 Relationship Between Extraintestinal Manifestations of Crohn's Disease and Patient-Reported and Disease Activity Outcomes in Adalimumab-Treated Patients in the Care Trial

✍ Walter Reinisch; Robert Lofberg; Edouard Louis; Andrew P. Yu; Joshua McHale; Nic 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 171 KB

P061 - Reduction in extraintestinal mani

P061 - Reduction in extraintestinal manifestations of Crohn's disease is associated with improvements in patient-reported and disease activity outcomes in patients treated with adalimumab

✍ Reinisch, W.; Lofberg, R.; Louis, E.; Yu, A.P.; McHale, J.; Beaulieu, N.; Mulani 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 48 KB

Splenic granulomas in a patient with sev

Splenic granulomas in a patient with severe Crohn's disease associated with multiple extraintestinal manifestations

✍ Lucia Castellani; Alessandro Sartini; Margherita Marocchi; Tiziana Balbi; Andrea 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB 👁 2 views

Adalimumab safety in global clinical tri

Adalimumab safety in global clinical trials of patients with Crohn's disease

✍ Jean-Frédéric Colombel; William J. Sandborn; Remo Panaccione; Anne M. Robinson; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 2 views

Background: Adalimumab, a fully human anti-tumor necrosis factor (anti-TNF) monoclonal antibody, is approved for the treatment of Crohn's disease (CD) in adults. We evaluated the overall safety profile of adalimumab in global clinical trials in patients with CD. Patients who participated in these tr